Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active Pharmaceutical Ingredient (API) for COVID-19 Treatment); Kalamazoo, Michigan, 11410 [2022-04225]
Download as PDF
11410
Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
Legal Authority:
Census Authority: Title 13, United
States Code (U.S.C.), Section 8(b) (13
U.S.C. 8(b)).
HRSA MCHB Authority: Section
501(a)(2) of the Social Security Act (42
U.S.C. 701).
United States Department of
Agriculture Authority: Agriculture
Improvement Act of 2018, Public Law
115–334.
United States Department of Health
and Human Services’ Centers for
Disease Control and Prevention,
National Center on Birth Defects and
Developmental Disabilities Authority:
Public Health Service Act, Section 301,
42 U.S.C. 241.
United States Department of Health
and Human Services’ Centers for
Disease Control and Prevention,
National Center for Chronic Disease
Prevention and Health Promotion
Authority: Sections 301(a), 307, and
399G of the Public Health Service [42
U.S.C. 241(a), 242l, and 280e–11], as
amended.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
publication of this notice on the
following website www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
entering either the title of the collection
or the OMB Control Number 0607–0990.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2022–04224 Filed 2–28–22; 8:45 am]
BILLING CODE 3510–07–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
jspears on DSK121TN23PROD with NOTICES1
[B–6–2022]
Foreign-Trade Zone (FTZ) 43—Battle
Creek, Michigan; Notification of
Proposed Production Activity; Pfizer,
Inc. (Nirmatrelvir Active
Pharmaceutical Ingredient (API) for
COVID–19 Treatment); Kalamazoo,
Michigan
activity to the FTZ Board for its facility
Kalamazoo, Michigan. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on February 22, 2022.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status materials/
components and specific finished
product described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz. The proposed finished product and
materials/components would be added
to the production authority that the
Board previously approved for the
operation, as reflected on the Board’s
website.
The proposed finished product is
Nirmatrelvir API (duty rate, 6.5%).
The proposed foreign-status materials
and components include Registered
Starter Chemical PF-04349713-01,
Registered Starter Chemical PF07321787, Registered Starter Chemical
PF-07328614-01, 2-Hydroxypyridine-Noxide (HOPO), and
Dimethylaminopropylethyl
carbodiimide hydrochloride (EDC HCI)
(duty rates are 3.7% or 6.5%). The
request indicates that certain materials/
components are subject to duties under
Section 301 of the Trade Act of 1974
(Section 301), depending on the country
of origin. The applicable Section 301
decisions require subject merchandise
to be admitted to FTZs in privileged
foreign status (19 CFR 146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is April
11, 2022.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact Diane
Finver at Diane.Finver@trade.gov.
Dated: February 23, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022–04225 Filed 2–28–22; 8:45 am]
BILLING CODE 3510–DS–P
Pfizer, Inc. (Pfizer) submitted a
notification of proposed production
VerDate Sep<11>2014
19:01 Feb 28, 2022
Jkt 256001
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
DEPARTMENT OF COMMERCE
International Trade Administration
[A–580–836]
Certain Cut-to-Length Carbon-Quality
Steel Plate Products From the
Republic of Korea: Preliminary Results
of Antidumping Duty Administrative
Review; 2020–2021
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) preliminarily finds that
producers/exporters subject to this
administrative review made sales of
subject merchandise at less than normal
value during the period of review (POR),
February 1, 2020, through January 31,
2021. We invite interested parties to
comment on these preliminary results of
review.
DATES: Applicable March 1, 2022.
FOR FURTHER INFORMATION CONTACT:
Andre Gziryan, AD/CVD Operations,
Office I, Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington,
DC 20230; telephone: (202) 482–2201.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On February 10, 2000, Commerce
published in the Federal Register an
antidumping duty order on certain cutto-length carbon-quality steel plate
products (CTL plate) from the Republic
of Korea (Korea).1 On February 2, 2021,
we published in the Federal Register a
notice of opportunity to request an
administrative review of the Order.2 On
April 1, 2021, based on timely requests
for an administrative review Commerce
initiated the administrative review of
four companies.3
On October 14, 2021, Commerce
extended the time limit for issuing the
preliminary results of this review by 117
days, to no later than February 25,
2022.4 For a complete description of the
1 See Notice of Amendment of Final
Determinations of Sales at Less Than Fair Value
and Antidumping Duty Orders: Certain Cut-ToLength Carbon-Quality Steel Plate Products from
France, India, Indonesia, Italy, Japan and the
Republic of Korea, 65 FR 6585 (February 10, 2000)
(Order).
2 See Antidumping or Countervailing Duty Order,
Finding, or Suspended Investigation; Opportunity
to Request Administrative Review, 86 FR 7855
(February 2, 2021).
3 See Initiation of Antidumping and
Countervailing Duty Administrative Reviews, 86 FR
17124 (April 1, 2021) (Initiation Notice).
4 See Memorandum, ‘‘Certain Cut-to-Length
Carbon-Quality Steel Plate Products from the
Republic of Korea: Extension of Deadline for
E:\FR\FM\01MRN1.SGM
01MRN1
Agencies
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Page 11410]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04225]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-6-2022]
Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan; Notification
of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active
Pharmaceutical Ingredient (API) for COVID-19 Treatment); Kalamazoo,
Michigan
Pfizer, Inc. (Pfizer) submitted a notification of proposed
production activity to the FTZ Board for its facility Kalamazoo,
Michigan. The notification conforming to the requirements of the
Board's regulations (15 CFR 400.22) was received on February 22, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status materials/components and
specific finished product described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz. The proposed finished
product and materials/components would be added to the production
authority that the Board previously approved for the operation, as
reflected on the Board's website.
The proposed finished product is Nirmatrelvir API (duty rate,
6.5%).
The proposed foreign-status materials and components include
Registered Starter Chemical PF-04349713-01, Registered Starter Chemical
PF-07321787, Registered Starter Chemical PF-07328614-01, 2-
Hydroxypyridine-N-oxide (HOPO), and Dimethylaminopropylethyl
carbodiimide hydrochloride (EDC HCI) (duty rates are 3.7% or 6.5%). The
request indicates that certain materials/components are subject to
duties under Section 301 of the Trade Act of 1974 (Section 301),
depending on the country of origin. The applicable Section 301
decisions require subject merchandise to be admitted to FTZs in
privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is April 11, 2022.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
[email protected].
Dated: February 23, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-04225 Filed 2-28-22; 8:45 am]
BILLING CODE 3510-DS-P